天堂v在线观看_av韩日_天天综合色网_人妻少妇偷人精品无码_最好看的2018中文中国话视频_成人区人妻精品一区二_欧美日韩一区二区三区在线电影_国产亚洲欧美在线_欧美精品在线一区二区三区_亚洲人成高清_吻胸摸全身视频_久久免费视频6_91福利影院_九九资源网_毛片基地站

Since the completion acceptance on July 10, 2020, Runan Pharmaceutical has actively improved various normative acceptance since the trial production, and has held 12 acceptance review meetings in total.

On April 17, 2020 the lightning protection devices of building facilities passed the completion acceptance of Huai'an Meteorological Bureau;

On May 11, 2020  Class C buildings passed the acceptance of Huai'an Salt Chemical New Materials Industrial Park Housing and Urban Rural Construction Bureau (fire acceptance)

On June 11,2020 Class A buildings passed the acceptance of Huai'an Housing and Urban Rural Development Bureau; (Fire acceptance)

On June 12,2020  the preparation of the "Emergency Plan for Enterprises and Public Institutions for Environmental Emergencies" passed the acceptance, and obtained the filing certificate from the Salt Chemical New Materials Industrial Park Branch of Huai'an Environmental Protection Bureau;

On June 20,2020  the members of the park's safety expert group reviewed the design changes of the "API production base project"

On July 7, 2020 it obtained the "Pollution Discharge Permit" issued by Huai'an Ecological Environment Bureau;

The "Phase II Safety Trial Production (Use) Scheme" prepared on September 27 passed the review of the members of the safety expert group;

The "Emergency Plan for Production Safety Accidents" prepared on October 26 passed the review of the members of the safety expert group;

The "Three Simultaneities of Safety Facilities Completion Acceptance" plan prepared on December 10 passed the review of the members of the safety expert group;

The "Three Simultaneities for Completion Acceptance of Environmental Protection Facilities" plan prepared on December 11 passed the review of the members of the expert group.

The "Occupational Health Control Effect" plan prepared on January 9, 2021 was reviewed by the leaders of the Municipal Health and Family Planning Commission and members of the expert group.

All normative acceptance of Runan Pharmaceutical will be completed before February 5, including online publicity.